Women who come to me for breast augmentation in Dubai ask about the scar before they ask about anything else. Where will it be. How long. Will it show. The question is entirely reasonable and it is aimed at the wrong thing.
A scar is not the price of an implant. It is the record of which door the surgeon chose, and the door is chosen for reasons that have nothing to do with beauty. One of the three routes into the breast passes directly through the ducts, where the resident bacteria of the breast live. The other two do not. That is the only difference the anatomy actually dictates. Everything else that separates them is a matter of what the surgeon does once he is inside, and no incision has ever made a careless operation safe.
Key takeaways: geography is not safety
- Scarless means no scar on the breast. It does not mean no scar.
- Only the periareolar route crosses the breast ducts, where the flora lives.
- The axillary and inframammary routes both avoid the ducts entirely.
- The axillary approach is the longest and least forgiving dissection of the three.
- Its literature is about process, selection and technique, not about superiority.
- An incision is not safe or unsafe. A surgeon is careful, or he is not.
A note on scope. This article is about the choice of incision and what that choice actually buys. It does not describe the operation, the implants, candidacy or recovery, all of which sit on my page about breast augmentation in Dubai. Nor does it set out the protocol for reducing bacterial load in the pocket, which I describe in my article on what actually prevents capsular contracture. What follows is the reasoning that precedes both.
The word means what it says, and no more
I use the term scarless breast augmentation, and I want to be exact about what I am claiming. There is a scar. It lies in the armpit, in a natural crease, and after a year it is difficult to find. What there is not is any incision anywhere on the breast.
That is a claim about geography. It is not a claim about safety, and I have watched a great deal of marketing quietly slide from the first to the second. A scar that has been relocated has been relocated. It has not been abolished, and the operation that relocated it has not thereby been made safer.
The honest question is not where the scar will be. It is what the surgeon crossed to get there, and what he did once he arrived.
Three doors into one room
Every approach to breast augmentation ends in the same place: a pocket, and an implant inside it. What differs is the corridor.
- Periareolar. An incision around the border of the nipple, passing through breast tissue to reach the pocket. It is the shortest route. It is also the only one of the three that traverses the breast ducts.
- Inframammary. An incision in the fold beneath the breast, entering under the gland. Short, direct, and it crosses no ducts at all. The scar is on the breast, hidden in a crease.
- Transaxillary. An incision in the armpit, with the pocket dissected endoscopically from a distance. It crosses no ducts, and it does not enter the breast at all. The scar lies outside the aesthetic unit of the chest entirely.
Notice what that list does and does not settle. It settles one thing definitively, and it leaves the rest open.
The ducts are the reason
Capsular contracture is driven, on the prevailing evidence, by bacteria reaching the implant surface and establishing a biofilm there. The response that follows is inflammatory, chronic, and it is what tightens a capsule around a device. What that capsule does once it has already tightened, and what the evidence actually supports doing about it, is a separate subject that I set out in my article on why capsular contracture treatment has no algorithm.
The breast is not sterile. Intraoperative cultures taken from twenty-five women during breast reduction found endogenous bacteria in counts higher than normal skin flora, concentrated in the region with the most ductal tissue, which is the periareolar region; the authors observed that this may be worth weighing when an incision site for augmentation is chosen. A nipple shield exists as a piece of surgical equipment for exactly that reason.
A periareolar incision passes an implant through that. Not past it. Through it. The mechanistic disadvantage is not a matter of opinion or of surgical preference; it follows from where the incision is placed and what lies between it and the pocket.
The inframammary and axillary routes do not cross the ducts. On this axis, and it is the axis that matters most, they are on the same side of the argument, and the periareolar incision is on the other.
The three routes into the breast, what each crosses, and why the anatomy settles only one question — by Dr. Nazmi Baycin, Dubai.
What the armpit actually trades
Having established what the axillary route avoids, let me be equally precise about what it costs, because this is the part that marketing omits.
What it gives. No incision anywhere on the breast. No duct opened, no duct divided. The nerve supply to the nipple, which arrives from the side of the chest rather than from the areola, is left entirely undisturbed. And a scar sited in a natural crease, lying under no tension, on skin that has spent a lifetime concealing itself.
What it demands. The pocket is dissected at arm’s length, remotely, through a corridor, guided by an endoscope rather than by a hand that can feel where it is. The implant travels further than in any other approach. The inframammary fold cannot simply be opened; it must be created, from above, at a distance, and it must be created symmetrically on both sides of a chest that is not symmetric.
Every one of those is a difficulty. Not one of them is a reason to avoid the operation. They are the reasons it is performed by comparatively few surgeons, and the reasons it should be.
| The question | What patients assume | What is actually true | What I do |
|---|---|---|---|
| Scarless | There is no scar | There is no scar on the breast | Say exactly that |
| The ducts | Irrelevant to the incision | Only periareolar crosses them | Never cross them |
| Safety by route | One incision is safest | The pocket decides, not the door | Control the pocket |
| The axillary route | Easier, because less invasive | The longest, least forgiving dissection | Endoscopic, never blind |
| Nipple sensation | Always at risk | Its nerves lie away from the areola | Approach from the side |
| The literature | Proves one approach superior | Describes process and selection | Follow the process |
Read the titles of the papers
There is a habit in this field of citing a study for the conclusion one wishes it had reached. The two foundational papers on this approach are worth reading for their titles alone.
The first is Axillary Endoscopic Breast Augmentation: Processes Derived From a 28-Year Experience to Optimize Outcomes. Twenty-eight years, and the word in the title is processes. Not advantages. Not superiority. Processes.
The second is Endoscopic-Assisted Transaxillary Breast Augmentation: Minimizing Complications and Maximizing Results With Improvements in Patient Selection and Technique. Selection. Technique. Not the incision.
Neither paper argues that the armpit is a safer place to begin. Both describe, at length and in detail, what a surgeon must do in order to make it safe. That is a very different claim, and it happens to be the true one.
The approach does not confer discipline. It requires it, and it punishes its absence more visibly than any other route, because a pocket made badly at a distance cannot be corrected by a hand that is nowhere near it.
Why comparisons between incisions mislead
Patients occasionally arrive with a figure they have found, comparing complication rates by incision. I treat those figures with considerable caution, and so should you.
The transaxillary approach was first described as a blunt and blind technique, in which the pocket was dissected without direct vision, carrying the hazards you would expect of any dissection performed by feel: hematoma, unpredictable extent, an inframammary fold that could not be reliably positioned. The endoscope changed that entirely, giving the surgeon complete visualization of the dissection and control over precisely where the implant sits.
Pooled comparisons of this approach draw substantially on the era before that change. They are, in significant part, comparing an operation nobody should still be performing against operations that have not stood still either. Modern endoscopic transaxillary surgery has not been separately isolated and tested. Anyone quoting you a number from that literature, in either direction, has not read where the number came from.
What I can tell you is mechanistic rather than statistical. The ducts are crossed or they are not. The pocket is entered cleanly or it is not. The implant is handled by a funnel and never by a glove, or it is not. Those are facts about an operation rather than averages across a heterogeneous literature, and they are what I would want to know if I were the patient.
Sensation, and what can honestly be said
The nipple takes its sensation chiefly from a branch of the fourth intercostal nerve, which reaches it from the lateral chest wall rather than from the areola. This is anatomy, and it has a practical consequence.
An incision placed at the areolar border lies across the territory of the nerves that supply it. An incision placed in the axilla does not. The axillary approach therefore carries a genuinely lower risk to nipple sensation, and that is a real advantage which I am glad to claim.
What I will not tell you is that the risk is zero. No operation on a breast carries a zero risk to the sensation of a breast. Numbness, hypersensitivity or an altered quality of sensation can follow any augmentation, by any route, and although it usually resolves it does not always. A surgeon who promises you zero has told you something about himself rather than about the operation.
The same anatomical logic applies to the ducts and to lactation. An approach that opens no duct and divides no duct leaves the breast’s capacity to feed a child structurally intact, and that is a considerable thing to preserve in a woman who may want it a decade from now.
Who the armpit does not suit
A surgeon’s willingness to refuse an operation tells you more than his enthusiasm for it.
The axillary route suits a woman with breasts that are small and undeveloped rather than sagging, with skin that has not been stretched, and who has not had previous breast surgery. It creates a fold; it does not repair one.
Where there is genuine ptosis, an implant will not lift the breast, and inserting one through the armpit will produce a fuller breast that still sits low. Those patients need a breast lift in Dubai, with or without an implant, and telling them otherwise in order to sell them a scarless operation would be a small dishonesty with a long consequence. Where a device is already present and the question is what to do about it, the conversation turns to breast implant exchange in Dubai or to breast implant removal in Dubai, and neither is well served by the axilla.
Nearly a thousand of these operations have taught me chiefly which women should not have one.
The door and the room
I perform the axillary approach because it puts no scar on the breast, because it opens no duct, and because it leaves the nerves to the nipple where it found them. Those are true, they are worth having, and they are all statements about location.
What makes the operation safe is none of them. It is what is done inside the pocket in the minutes before the device arrives, and that protocol — along with the evidence for it, and the evidence against the exercise patients are usually given instead — is the subject of my article on what actually prevents capsular contracture. It can be done well or badly through any incision, and it is what actually determines whether a breast is still soft in five years.
So do not ask a surgeon where your scar will be. Ask him what he will do once he is inside. Ask him what he irrigates the pocket with, and whether the implant will touch his glove, and how he will make your fold. If he answers only by describing the incision, he has told you about the door and nothing at all about the room. That is the standard I hold at my plastic surgery clinic in Dubai, and it is why I would rather explain what an incision cannot do than sell you a word.
FAQs about scarless breast augmentation in Dubai
-
Is scarless breast augmentation really without any scar?
No, and I want to be exact. There is a scar. It lies in the armpit, in a natural crease, under no tension, and after a year it is difficult to find. What there is not is any incision anywhere on the breast. That is the whole of the claim, and it is a claim about geography rather than about safety. So a scar that has been relocated has been relocated. It has not been abolished, and the operation that moved it has not thereby been made safer. Anyone who slides from the first statement to the second is selling you a word.
-
Which breast augmentation incision is safest?
That question has one clear answer and one honest non-answer. The clear answer concerns the periareolar route, which passes the implant directly through the breast ducts, where the resident flora of the breast lives. That is a mechanistic disadvantage dictated by anatomy. Neither the inframammary nor the axillary route crosses the ducts. On the axis that matters most, they sit on the same side of the argument. So between those two, the anatomy is silent, and what speaks is the surgeon. An incision is not safe or unsafe. The pocket decides, not the door.
-
Why does the incision matter for capsular contracture?
Because contracture is driven by bacteria reaching the implant surface and forming a biofilm there, provoking a chronic inflammatory response that tightens the capsule. The breast is not sterile. Its ducts carry a resident flora, which is why nipple shields exist as surgical equipment at all. A periareolar incision passes an implant through that flora, rather than past it. So the route determines only whether the ducts are crossed. Everything else that protects you happens inside the pocket, and I set that protocol out in a separate article, because it is the part that actually decides the result.
-
Is the transaxillary approach easier or less invasive?
Neither, and I would distrust anyone who says so. It is the longest and least forgiving dissection of the three approaches. The pocket is dissected at arm’s length, remotely, through a corridor, guided by an endoscope rather than by a hand that can feel where it is. The implant travels further than by any other route. The inframammary fold cannot simply be opened; it must be created, from above, at a distance, and symmetrically on a chest that is not symmetric. So none of that is a reason to avoid the operation. It is the reason comparatively few surgeons perform it, and the reason they should.
-
Does breast augmentation through the armpit affect nipple sensation?
Less than a periareolar incision does, and for a straightforward anatomical reason. The nipple takes its sensation chiefly from a branch of the fourth intercostal nerve, which reaches it from the lateral chest wall rather than from the areola. An incision at the areolar border lies across the territory of those nerves. An incision in the armpit does not. So the axillary approach carries a genuinely lower risk to nipple sensation, and I am glad to claim it. So what I will not tell you is that the risk is zero. No operation on a breast carries a zero risk to the sensation of a breast. A surgeon who promises you zero has told you something about himself.
-
Can I still breastfeed after scarless breast augmentation?
The anatomical basis for it is preserved, which is the honest way to answer. An approach that opens no duct and divides no duct leaves the breast’s structural capacity to feed a child intact. That is not the same as a guarantee. Lactation depends on a great deal besides ductal continuity, and no surgeon can promise a woman that she will feed successfully, whether or not she has had an implant. So what I can tell you is what was and was not cut. In a transaxillary augmentation, no part of the ductal system is traversed at all, and that is a considerable thing to preserve in a woman who may want it a decade from now.
-
Why should I distrust comparisons of complication rates between incisions?
Because of what is inside them. The transaxillary approach was first described as a blunt and blind technique, in which the pocket was dissected without direct vision, carrying the hazards of any dissection performed by feel. The endoscope changed that entirely, giving complete visualization of the dissection and control over where the implant sits. Pooled comparisons draw substantially on the era before that change. So they are in significant part comparing an operation nobody should still be performing. Modern endoscopic transaxillary surgery has not been separately isolated and tested. Anyone quoting you a figure from that literature, in either direction, has not read where it came from.
-
Who is not a candidate for the armpit approach?
Any woman with genuine sagging, and this is where a surgeon’s willingness to refuse tells you more than his enthusiasm. The axillary route suits breasts that are small and undeveloped rather than ptotic, skin that has not been stretched, and a woman who has not had previous breast surgery. It creates a fold. It does not repair one. So where there is real ptosis, an implant will not lift the breast, and inserting one through the armpit produces a fuller breast that still sits low. Those patients need a lift, with or without an implant. Telling them otherwise in order to sell a scarless operation would be a small dishonesty with a long consequence.
GET APPOINTMENT
Get ready to look and feel best… You deserve…
